AMENDMENT No. 2 TO OFFER LETTER AGREEMENTOffer Letter Agreement • September 22nd, 2022 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
This AMENDMENT NO. 2 TO OFFER LETTER AGREEMENT (the “Amendment”) is effective as of September 18, 2022 (“Amendment Effective Date”), by and between BRAINSTORM CELL THERAPEUTICS INC., a Delaware corporation with a mailing address of 1325 Avenue of Americas, 28th Floor New York, NY 10019(the “Company”), and DR. STACY LINDBORG, an individual, with a mailing address of (the “Executive”).
